ARTICLE | Clinical News
Lipitor atorvastatin regulatory update
March 29, 2010 7:00 AM UTC
The CHMP recommended the approval of a chewable formulation of Sortis atorvastatin from Pfizer to treat hypercholesterolaemia in adolescents and children ages 10 or older. The committee also recommend...